 |
 |
 |
 |
 |
 |
 |
 |
 |
Protez Pharmaceuticals
Protez Pharmaceuticals develops new antibiotics to combat the growing problem of drug resistance, as well as agents that improve the efficacy of current antibiotics. The Company's focus is difficult-to-treat hospital-based infections. Protez was acquired by Novartis in June 2008.